Diabetes in the MENA Region: Challenges and Solutions

By Melike Belenli Gümüş

November 12, 2024

A recent article on the Diabetes Voice, the quarterly magazine of the International Diabetes Federation (IDF), offers a detailed examination of the diabetes epidemic specifically affecting the Middle East and North Africa (MENA) region. This comprehensive overview highlights the pressing issue of diabetes in the MENA region and the various challenges it poses.

Rising Prevalence of Diabetes

Diabetes is increasingly prevalent in the MENA region, driven by factors such as rapid economic growth, urbanisation, and lifestyle changes. With a staggering 12.2% diabetes prevalence, the MENA region faces projections of an alarming 86% increase by 2045.

Disparities in Healthcare Access

Access to healthcare, particularly specialised diabetes care, is limited, especially in rural areas of the MENA region. Fewer than 1 in 10 individuals with type 2 diabetes in low- and middle-income countries, including MENA, receive comprehensive guideline-based treatment.

Undiagnosed Diabetes

A significant portion of people with diabetes in the MENA region remain undiagnosed. In 2019, it was estimated that 44.7% of those affected were unaware of their condition. This lack of diagnosis varies by country, from 17.4% in Jordan to over 35% in parts of Egypt. Undiagnosed diabetes is notably prevalent among older populations, emphasising the need for enhanced screening programs.

Barriers to Treatment

After diagnosis, accessing quality, affordable care remains a challenge due to high costs of insulin, medications, and supplies. Economic constraints in many MENA countries worsen these issues. This results in critically low health expenditures on diabetes. Consequently, patients face significant barriers to proper care.

Cultural and Socioeconomic Factors

Cultural perspectives, such as traditional diets and lifestyle habits, can significantly hinder effective diabetes management. Furthermore, cultural stigmas and a general lack of awareness about diabetes can deter people from seeking timely care and adhering to treatment plans.

Specific Risk Factors for Women

Women in the MENA region face unique diabetes risk factors, including obesity and low physical activity levels. Pregnant women are particularly vulnerable to hyperglycemia and developing gestational diabetes mellitus (GDM), especially in Gulf Cooperation Council (GCC) countries and North African regions. Currently, 1 in 7 live births is affected by GDM, increasing the risk of both mothers and babies developing diabetes later in life.

Impact of Crises

The region is frequently affected by both natural and human-made crises, including conflicts, political instability, and sanctions. These disruptions significantly impair healthcare systems and create barriers to diabetes treatment and care for refugees and internally displaced individuals. Often, resources are diverted to immediate emergency care, leaving chronic conditions like diabetes inadequately funded and poorly managed.

Recommendations for Improvement

To combat these challenges, governments in the MENA region must improve access to education for healthcare providers and the public, raise awareness, and implement comprehensive national strategies. This effort should emphasise better resource allocation and the deployment of cost-effective solutions to address the growing health crisis of diabetes.

In conclusion, the article highlights the urgent need for improved healthcare infrastructure, increased public awareness, and comprehensive policy initiatives to effectively manage and prevent diabetes in the MENA region. Addressing the diabetes epidemic is not only essential for public health but also vital for enhancing the quality of life for individuals across the region.

Reference url

Recent Posts

hepatitis C treatment options
       

VIETNARMS Trial Unveils Innovative Hepatitis C Treatment Options

🔍 Are you curious about the latest advancements in hepatitis C treatment options?

The groundbreaking VIETNARMS trial reveals that sofosbuvir-daclatasvir offers a comparable efficacy to sofosbuvir-velpatasvir while exploring innovative strategies that could reshape treatment accessibility and affordability. With cure rates exceeding 90%, these findings hold promise for improving outcomes, especially in underserved populations.

Dive into the full article to uncover how these developments could revolutionize hepatitis C care!

#SyenzaNews #globalhealth #HealthcareInnovation

hepatitis C treatment
    

Revolutionizing Hepatitis C Treatment: The Transformative Role of Direct-Acting Antivirals

💡 How are direct-acting antivirals (DAAs) revolutionizing hepatitis C treatment?

The rise of DAAs has led to cure rates between 95-99%, shifting the landscape of hepatitis C care. As we strive for the global eradication goal by 2030, understanding the market dynamics and expanding patient access becomes crucial.

Dive into the article to explore how these advancements impact health economics and public health strategies.

#SyenzaNews #HealthEconomics #HealthcareInnovation #MarketAccess

hepatitis C investment impact
         

Hepatitis C Investment Impact: Maximizing Health and Economic Returns in China

💰 What could a staggering $1.17 trillion economic toll mean for the future of healthcare in China?

This article reviews the economic impacts of hepatitis C and highlights how an investment of $69.72 billion could prevent over a million deaths and unlock significant societal gains. Accelerating efforts to meet WHO targets isn’t just a health imperative – it’s a financial opportunity we can’t afford to overlook.

Explore the insights and find out how transformative investments can reshape the landscape of health and economics.

#SyenzaNews #HealthEconomics #HealthcarePolicy #CostEffectiveness

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.